1-112647271-A-G
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_006135.3(CAPZA1):āc.101A>Gā(p.Asn34Ser) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000485 in 1,484,060 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_006135.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAPZA1 | NM_006135.3 | c.101A>G | p.Asn34Ser | missense_variant, splice_region_variant | 2/10 | ENST00000263168.4 | NP_006126.1 | |
CAPZA1 | XM_017002424.3 | c.101A>G | p.Asn34Ser | missense_variant, splice_region_variant | 2/10 | XP_016857913.1 | ||
CAPZA1 | XM_011542225.4 | c.101A>G | p.Asn34Ser | missense_variant, splice_region_variant | 2/9 | XP_011540527.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAPZA1 | ENST00000263168.4 | c.101A>G | p.Asn34Ser | missense_variant, splice_region_variant | 2/10 | 1 | NM_006135.3 | ENSP00000263168.3 | ||
CAPZA1 | ENST00000476936.5 | n.127A>G | splice_region_variant, non_coding_transcript_exon_variant | 2/8 | 3 | |||||
CAPZA1 | ENST00000485542.5 | n.141A>G | splice_region_variant, non_coding_transcript_exon_variant | 2/3 | 2 | |||||
CAPZA1 | ENST00000498626.1 | n.154A>G | splice_region_variant, non_coding_transcript_exon_variant | 3/9 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152234Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000854 AC: 19AN: 222458Hom.: 0 AF XY: 0.000124 AC XY: 15AN XY: 121130
GnomAD4 exome AF: 0.0000511 AC: 68AN: 1331708Hom.: 0 Cov.: 22 AF XY: 0.0000621 AC XY: 41AN XY: 660514
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152352Hom.: 0 Cov.: 32 AF XY: 0.0000268 AC XY: 2AN XY: 74496
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 19, 2024 | The c.101A>G (p.N34S) alteration is located in exon 2 (coding exon 2) of the CAPZA1 gene. This alteration results from a A to G substitution at nucleotide position 101, causing the asparagine (N) at amino acid position 34 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at